Amturnide Side Effects

Generic name: aliskiren / amlodipine / hydrochlorothiazide

Medically reviewed by Drugs.com. Last updated on Oct 27, 2023.

Note: This document provides detailed information about Amturnide Side Effects associated with aliskiren / amlodipine / hydrochlorothiazide. Some dosage forms listed on this page may not apply specifically to the brand name Amturnide.

Applies to aliskiren / amlodipine / hydrochlorothiazide: oral tablet.

Important warnings This medicine can cause some serious health issues

You should not use this medicine if you are unable to urinate, or if you are allergic to sulfa drugs.

Do not use if you are pregnant. Stop using and tell your doctor right away if you become pregnant.

If you have diabetes, you should not use this medicine together with certain heart or blood pressure medicines (such as Accupril, Benicar, Capoten, Cozaar, Diovan, Lotensin, Mavik, Prinivil, Vasotec, and many others).

Get emergency medical help if you have any of these signs of an allergic reaction while taking aliskiren/amlodipine/hydrochlorothiazide: hives; vomiting, severe stomach pain; dizziness, difficulty breathing; swelling of your face, lips, tongue, or throat.

Your chest pain may become worse when you first start taking the medicine or when your dose is increased. Tell your doctor if your chest pain is severe or ongoing.

Call your doctor at once if you have:

• a light-headed feeling, like you might pass out;

• little or no urinating;

• eye pain, vision problems;

• low levels of sodium in the body--headache, confusion, slurred speech, severe weakness, vomiting, loss of coordination, feeling unsteady;

• high potassium--slow heart rate, weak pulse, muscle weakness, tingly feeling);

• low potassium--confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling;

• lupus-like symptoms--joint pain with fever, skin sores, butterfly-shaped skin rash on your cheeks and nose, numbness or pale appearance of your fingers or toes;

• liver problems--nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

• severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Common side effects may include:

• swelling in your hands, ankles, or feet;

• headache, dizziness, tired feeling;

• cough;

• diarrhea; or

• cold symptoms such as stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to aliskiren / amlodipine / hydrochlorothiazide: oral tablet.

Cardiovascular

Aliskiren:

• Rare (less than 0.1%): Hypotension

Amlodipine:

• Common (1% to 10%): palpitations
• Uncommon (0.1% to 1%): Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, hypotension, peripheral ischemia, postural hypotension, tachycardia, vasculitis
• Rare (less than 0.1%): Myocardial infarction, angina

Hydrochlorothiazide:

• Frequency not reported: Cardiac arrhythmias (including ventricular ectopy and complete AV heart block), hypotension, orthostatic hypotension (more common in the elderly)^[Ref]

Dermatologic

Aliskiren:

• Common (1% to 10%): Rash
• Rare (less than 0.1%): Angioedema (involving the face, hands, or whole body)
• Postmarketing reports: Severe cutaneous adverse reactions (including Stevens Johnson syndrome and toxic epidermal necrolysis)

Amlodipine:

• Common (1% to 10%): Rash, erythematous rash
• Uncommon (0.1% to 1%): Angioedema, erythema multiforme, increased sweating, maculopapular rash, pruritus
• Rare (less than 0.1%): Alopecia, dermatitis, skin discoloration, skin dryness, urticaria, lichen planus, telangiectasia

Hydrochlorothiazide:

• Rare (less than 0.1%): Erythema annular centrifugum, acute eczematous dermatitis, morbilliform and leukocytoclastic vasculitis, phototoxic dermatitis
• Frequency not reported: Subacute cutaneous lupus erythematosus like reaction^[Ref]

Endocrine

Amlodipine:

• Postmarketing reports: Gynecomastia^[Ref]

Gastrointestinal

Aliskiren:

• Common (1% to 10%): Diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux (these side effects appear to be dose related)
• Postmarketing reports: Nausea, vomiting

Amlodipine:

• Common (1% to 10%): Nausea, dysphagia, abdominal pain
• Uncommon (0.1% to 1%): Anorexia, constipation, diarrhea, dry mouth, dyspepsia, flatulence, gingival hyperplasia, pancreatitis, vomiting
• Rare (less than 0.1%): Gastritis, increased appetite, loose stools, taste perversion, dysgeusia

Hydrochlorothiazide:

• Uncommon (0.1% to 1%): Nausea, vomiting, diarrhea^[Ref]

Genitourinary

Amlodipine:

• Uncommon (0.1% to 1%): Micturition disorder, micturition frequency, nocturia
• Rare (less than 0.1%): Dysuria, polyuria^[Ref]

Hematologic

Amlodipine:

• Uncommon (0.1% to 1%): Leukopenia, purpura, thrombocytopenia

Hydrochlorothiazide:

• Rare (less than 0.1%): Immune-complex hemolytic anemia, aplastic anemia, thrombocytopenia^[Ref]

Hepatic

• Common (1% to 10%): Occasional elevations (greater than 150% from baseline) in ALT (SGPT)

Amlodipine:

• Postmarketing reports: Jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis)-Some cases were severe enough to require hospitalization

Hydrochlorothiazide:

• Rare (less than 0.1%): Interstitial nephritis^[Ref]

Hypersensitivity

Aliskiren:

• Frequency not reported: Angioedema (face, hands, and body) with or without respiratory symptoms
• Postmarketing reports: Angioedema

Amlodipine:

• Uncommon (0.1% to 1%): Allergic reaction

Hydrochlorothiazide:

• Uncommon (0.1% to 1%): Rash
• Rare (less than 0.1%): Anaphylaxis^[Ref]

Metabolic

• Very rare (less than 0.01%): Hot flushes
• Frequency not reported: Edema, peripheral edema

Aliskiren:

• Uncommon (0.1% to 1%): Elevated uric acid, gout, renal stones
• Postmarketing reports: Peripheral edema, hyponatremia

Amlodipine:

• Uncommon (0.1% to 1%): Hyperglycemia, thirst, weight loss, weight gain
• Very rare (less than 0.01%): Acute porphyria exacerbation
• Frequency not reported: New-onset diabetes

Hydrochlorothiazide:

• Very common (10% or more): Mild hypokalemia (decrease of 0.5 mEq/L) occurs in up to 50% of patients, and may predispose patients to cardiac arrhythmias
• Common (1% to 10%): Metabolic alkalosis, hyponatremia, hypomagnesemia, hypercalcemia, hyperglycemia, elevated serum uric acid levels
• Very rare (less than 0.01%): Hot flushes
• Frequency not reported: Edema, peripheral edema, glucose intolerance, a potentially deleterious effect on the lipid profile (i.e., increased serum cholesterol)^[Ref]

Uric acid increase greater than 50% from baseline was more commonly observed in patients treated with aliskiren / amlodipine / hydrochlorothiazide (4.7%) compared with the dual combinations (0.4 to 2.8%). Gout was less commonly observed (0.3% in aliskiren / amlodipine / hydrochlorothiazide treated patients) and renal stones were not reported.

Immunologic

Hydrochlorothiazide:

• Common (1% to 10%): Rash that is histologically identical to subacute cutaneous lupus
• Frequency not reported: Allergic vasculitis, hemolytic anemia^[Ref]

Nervous system

• Uncommon (0.1% to 1%): Malaise, pain
• Frequency not reported: Fatigue

Aliskiren:

• Frequency not reported: Headache, dizziness, fatigue, episodes of tonic-clonic seizures with loss of consciousness

Amlodipine:

• Common (1% to 10%): Headache, dizziness, somnolence
• Uncommon (0.1% to 1%): Hypoesthesia, paresthesia, peripheral neuropathy, postural dizziness, syncope, tinnitus, tremor
• Rare (less than 0.1%): Migraine

Hydrochlorothiazide:

• Frequency not reported: Cerebrovascular insufficiency associated with hydrochlorothiazide-induced plasma volume contraction, cognitive and neurologic impairment (i.e., confusion, somnolence, feeling dazed)- Symptoms resolved following discontinuation of hydrochlorothiazide.^[Ref]

Musculoskeletal

• Uncommon (0.1% to 1%): Asthenia, rigors

Amlodipine:

• Common (1% to 10%): Myalgia
• Uncommon (0.1% to 1%): Arthralgia, arthrosis, muscle cramps
• Rare (less than 0.1%): Hypertonia, muscle weakness, twitching, ataxia

Hydrochlorothiazide:

• Uncommon (0.1% to 1%): Myalgias, chills, muscle spasms, preservation of mineral bone density in older patients^[Ref]

Ocular

Amlodipine:

• Uncommon (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain
• Rare (less than 0.1%): Abnormal visual accommodation, xerophthalmia

Hydrochlorothiazide:

• Frequency not reported: Transient blurred vision, acute transient myopia, acute angle-closure glaucoma, xanthopsia^[Ref]

Other

• Rare (less than 0.1%): Parosmia
• Frequency not reported: Tinnitus^[Ref]

Renal

Amlodipine:

• Rare (less than 0.1%): Interstitial nephritis

Hydrochlorothiazide:

• Rare (less than 0.1%): Renal insufficiency, renal failure, renal dysfunction, interstitial nephritis^[Ref]

Respiratory

Aliskiren:

• Frequency not reported: Nasopharyngitis, upper respiratory tract infection, cough

Amlodipine:

• Common (1% to 10%): Epistaxis
• Uncommon (0.1% to 1%): Dyspnea
• Rare (less than 0.1%): Coughing, rhinitis
• Postmarketing reports: Pulmonary edema was reported during a study of patients with NYHA Class III or IV heart failure without clinical symptoms or objective evidence of underlying ischemic disease.

Hydrochlorothiazide:

• Frequency not reported: Acute noncardiogenic pulmonary edema (these cases are thought to be due to idiosyncrasy or a hypersensitivity mechanism)^[Ref]

Further information

Amturnide side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer